BPI
TXG icon

BFC Planning, Inc.’s 10x Genomics TXG Stock Holding History

BFC Planning, Inc.’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Hold
375
– – ﹤0.01% 2174
2026
Q1 		$7.96K Sell
375
-8
-2% -$160 ﹤0.01% 2138
2025
Q4 		$6.25K Buy
383
+293
+326% +$4.43K ﹤0.01% 2264
2025
Q3 		$1.05K Hold
90
– – ﹤0.01% 2614
2025
Q2 		$1.04K Sell
90
-13
-13% -$118 ﹤0.01% 2442
2025
Q1 		$899 Buy
103
+13
+14% +$164 ﹤0.01% 2461
2024
Q4 		$1.29K Buy
+90
New +$1.42K ﹤0.01% 2362

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.5B AUM 50.54% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFC Planning, Inc.'s TXG Position: Q2 2026 in Review

BFC Planning, Inc. held its 10x Genomics (TXG) position steady in Q2 2026 at 375 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

BFC Planning, Inc. first reported a position in TXG in Q4 2024 and has held it in 7 quarters since. 396 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • BFC Planning, Inc. held 375 shares of 10x Genomics worth $14.4K as of Q2 2026.
  • BFC Planning, Inc. left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2174 holding.
  • BFC Planning, Inc. first reported a position in 10x Genomics in Q4 2024 and has held it in 7 quarters since.
  • 396 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.